Effects of Mesenchymal Stem Cell-Derived Paracrine Signals and Their Delivery Strategies

被引:134
|
作者
Chang, Calvin [1 ,2 ,3 ]
Yan, Jerry [1 ,2 ,3 ]
Yao, Zhicheng [2 ,3 ,4 ]
Zhang, Chi [2 ,3 ,4 ]
Li, Xiaowei [5 ,6 ]
Mao, Hai-Quan [1 ,2 ,3 ,4 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA
[2] Johns Hopkins Sch Med, Translat Tissue Engn Ctr, Baltimore, MD 21287 USA
[3] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD 21218 USA
[4] Johns Hopkins Univ, Dept Mat Sci & Engn, Whiting Sch Engn, Baltimore, MD 21218 USA
[5] Univ Nebraska Med Ctr, Mary & Dick Holland Regenerat Med Program, Omaha, NE 68198 USA
[6] Univ Nebraska Med Ctr, Dept Neurol Sci, Omaha, NE 68198 USA
关键词
biomaterials; extracellular vesicles; mesenchymal stem cells; microRNA; paracrine signaling; secretome; STROMAL CELLS; EXTRACELLULAR VESICLES; BONE-MARROW; THERAPY; TISSUE; ENGRAFTMENT; INJURY; MACROPHAGES; SPHEROIDS; EXOSOMES;
D O I
10.1002/adhm.202001689
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Mesenchymal stem cells (MSCs) have been widely studied as a versatile cell source for tissue regeneration and remodeling due to their potent bioactivity, which includes modulation of inflammation response, macrophage polarization toward proregenerative lineage, promotion of angiogenesis, and reduction in fibrosis. This review focuses on profiling the effects of paracrine signals of MSCs, commonly referred to as the secretome, and highlighting the various engineering approaches to tune the MSC secretome. Recent advances in biomaterials-based therapeutic strategies for delivery of MSCs and MSC-derived secretome in the form of extracellular vesicles are discussed, along with their advantages and challenges.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] Mesenchymal stem cell-derived exosomes for clinical use
    Mendt, Mayela
    Rezvani, Katayoun
    Shpall, Elizabeth
    BONE MARROW TRANSPLANTATION, 2019, 54 (Suppl 2) : 789 - 792
  • [42] Mesenchymal stem cell-derived exosomes for treatment of sepsis
    Homma, Kento
    Bazhanov, Nikolay
    Hashimoto, Kazuki
    Shimizu, Masaru
    Heathman, Thomas
    Hao, Qi
    Nawgiri, Ranjana
    Muthukumarana, Vidarshi
    Lee, Jae Woo
    Prough, Donald S. S.
    Enkhbaatar, Perenlei
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [43] Mesenchymal stem cell-derived exosomes for gastrointestinal cancer
    Lin-Xian Zhao
    Kai Zhang
    Bing-Bing Shen
    Jian-Nan Li
    World Journal of Gastrointestinal Oncology, 2021, 13 (12) : 1981 - 1996
  • [44] Mesenchymal stem cell-derived exosomes for clinical use
    Mayela Mendt
    Katayoun Rezvani
    Elizabeth Shpall
    Bone Marrow Transplantation, 2019, 54 : 789 - 792
  • [45] Mesenchymal stem cell-derived exosomes: Toward cell-free therapeutic strategies in regenerative medicine
    Ma, Zhan-Jun
    Yang, Jing-Jing
    Lu, Yu-Bao
    Liu, Zhao-Yang
    Wang, Xue-Xi
    WORLD JOURNAL OF STEM CELLS, 2020, 12 (08): : 814 - 840
  • [46] Mesenchymal stem cell-derived soluble factors and their instructive effects on neural stem and progenitor cells
    Hardy, Steven A.
    Croft, Adam P.
    Przyborski, Stefan A.
    JOURNAL OF ANATOMY, 2008, 212 (01) : 90 - 90
  • [47] Mesenchymal Stem Cell-Derived Extracellular Vesicles as Idiopathic Pulmonary Fibrosis Microenvironment Targeted Delivery
    Sang, Lu
    Guo, Xiaoqin
    Fan, Haojun
    Shi, Jie
    Hou, Shike
    Lv, Qi
    CELLS, 2022, 11 (15)
  • [48] Minimally Invasive Delivery of Mesenchymal Stem Cell-derived Exosomes Improves Heart Repair in Pigs
    Li, Yuan
    Tasoudis, Panagiotis
    Huang, Ke
    Cheng, Ke
    CIRCULATION RESEARCH, 2024, 135
  • [49] Bone formation of embryonic stem cell-derived mesenchymal stem cells
    Jung, Yeon Tae
    Yoo, Ki-Yeon
    Lee, Hee Su
    TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2015, 12 : 132 - 137
  • [50] Bone formation of embryonic stem cell-derived mesenchymal stem cells
    Yeon Tae Jung
    Ki-Yeon Yoo
    Hee Su Lee
    Tissue Engineering and Regenerative Medicine, 2015, 12 : 132 - 137